WallStreetZenWallStreetZen

NASDAQ: POM
Pomdoctor Ltd Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Pomdoctor earnings were -$55.2M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest POM earnings report on Jun 30, 2026 announced Q2 2026 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, POM reported annual earnings of -$30.4M, with 54.7% growth.

POM earnings history

Current Revenue
$60.4M
Current Earnings
-$54.5M
Current Profit Margin
-90.2%

POM Return on Equity

Insufficient data to display

POM Return on Assets

Current Company
-616.8%
Current Industry
-20.4%
POM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when POM announces earnings.

POM Return on Capital Employed

Current Company
255.95%
Current Industry
6.8%

POM vs Pharmaceutical Retailer Stocks

TickerEBITDAEarningsY/Y EarningsEPS
POMN/A-$55.21MN/A-$9.14
SCNX-$35.49M-$37.95MN/A-$53.00
MEDS-$80.02M-$88.28MN/A-$46.63
PETS-$20.47M-$29.28MN/A-$1.38
HKPD-$307.33k-$1.14MN/A-$1.38
View Top Pharmaceutical Retailer Stocks

Pomdoctor Earnings Reports & History FAQ

What were Pomdoctor's earnings last quarter?

On POM's earnings call on Aug 13, 2026, Pomdoctor (NASDAQ: POM) reported Q2 2026 earnings per share (EPS) of N/A, up N/A year over year. Total POM earnings for the quarter were N/A. In the same quarter last year, Pomdoctor's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Pomdoctor stock.

Is Pomdoctor profitable or losing money?

As of the last Pomdoctor earnings report, Pomdoctor is currently losing money. Pomdoctor's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$52.63 million, a 772.32% increase year over year.

What was POM's earnings growth in the past year?

As of Pomdoctor's earnings date in Aug 13, 2026, Pomdoctor's earnings has grown year over year. POM earnings in the past year totalled -$55.21 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.